UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry

Annals of the rheumatic diseases, 2014-12, Vol.73 (12), p.2160-2167

2014

Volltextzugriff (PDF)

Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis

Circulation (New York, N.Y.), 2016-06, Vol.133 (24), p.2404-2412

2016

Volltextzugriff (PDF)

Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials

British journal of dermatology (1951), 2012-01, Vol.166 (1), p.179-188

2012

Volltextzugriff (PDF)

Native T1 and Extracellular Volume in Transthyretin Amyloidosis

JACC. Cardiovascular imaging, 2019-05, Vol.12 (5), p.810-819

2019

Volltextzugriff (PDF)

Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component

The New England journal of medicine, 2015-09, Vol.373 (12), p.1106-1114

2015

Volltextzugriff (PDF)

Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis

The New England journal of medicine, 2013-08, Vol.369 (9), p.819-829

2013

Volltextzugriff (PDF)

Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome

The New England journal of medicine, 2009-06, Vol.360 (23), p.2416-2425

2009

Volltextzugriff (PDF)

Primary care provider practices and beliefs related to cervical cancer screening with the HPV test in Federally Qualified Health Centers

Preventive medicine, 2013-11, Vol.57 (5), p.419-425

2013

Volltextzugriff (PDF)

Efficacy of bortezomib, cyclophosphamide and dexamethasone in treatment-naïve patients with high-risk cardiac AL amyloidosis (Mayo Clinic stage III)

Haematologica (Roma), 2014-09, Vol.99 (9), p.1479-1485

2014

Volltextzugriff (PDF)

Natural History and Outcome in Systemic AA Amyloidosis

The New England journal of medicine, 2007-06, Vol.356 (23), p.2361-2371

2007

Volltextzugriff (PDF)

A study of implanted cardiac rhythm recorders in advanced cardiac AL amyloidosis

European heart journal, 2015-05, Vol.36 (18), p.1098-1105

2015

Volltextzugriff (PDF)

Bortezomib With or Without Dexamethasone in Primary Systemic (Light Chain) Amyloidosis

Journal of clinical oncology, 2010-02, Vol.28 (6), p.1031-1037

2010

Volltextzugriff (PDF)

Systemic Amyloidosis in England: an epidemiological study

British journal of haematology, 2013-05, Vol.161 (4), p.525-532

2013

Volltextzugriff (PDF)

Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis

European heart journal cardiovascular imaging, 2014-11, Vol.15 (11), p.1289-1298

2014

Volltextzugriff (PDF)

RAD21 cohesin overexpression is a prognostic and predictive marker exacerbating poor prognosis in KRAS mutant colorectal carcinomas

British journal of cancer, 2014-03, Vol.110 (6), p.1606-1613

2014

Volltextzugriff (PDF)

Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes

Annals of the rheumatic diseases, 2011-12, Vol.70 (12), p.2095-2102

2011

Volltextzugriff (PDF)

A matched comparison of cyclophosphamide, bortezomib and dexamethasone (CVD) versus risk-adapted cyclophosphamide, thalidomide and dexamethasone (CTD) in AL amyloidosis

Leukemia, 2014-12, Vol.28 (12), p.2304-2310

2014

Volltextzugriff (PDF)

Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein

The Lancet (British edition), 2001-07, Vol.358 (9275), p.24-29

2001

Volltextzugriff (PDF)

Extracellular volume quantification by dynamic equilibrium cardiac computed tomography in cardiac amyloidosis

Journal of cardiovascular computed tomography, 2015-11, Vol.9 (6), p.585-592

2015

Volltextzugriff (PDF)

Different APC genotypes in proximal and distal sporadic colorectal cancers suggest distinct WNT/β-catenin signalling thresholds for tumourigenesis

Oncogene, 2013-09, Vol.32 (39), p.4675-4682

2013

Volltextzugriff (PDF)

The effect of changes in cardiac output on middle cerebral artery mean blood velocity at rest and during exercise

The Journal of physiology, 2005-12, Vol.569 (2), p.697-704

2005

Volltextzugriff (PDF)

Therapeutic blockade of interleukin-6 by tocilizumab in the management of AA amyloidosis and chronic inflammatory disorders: a case series and review of the literature

Clinical and experimental rheumatology, 2015-11, Vol.33 (6 Suppl 94), p.S46

2015

Volltextzugriff (PDF)

Misdiagnosis of Hereditary Amyloidosis as AL (Primary) Amyloidosis

The New England journal of medicine, 2002-06, Vol.346 (23), p.1786-1791

2002

Volltextzugriff (PDF)

Safety and efficacy of risk-adapted cyclophosphamide, thalidomide, and dexamethasone in systemic AL amyloidosis

Blood, 2007-01, Vol.109 (2), p.457-464

2007

Volltextzugriff (PDF)

1 – 25 von 639

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(590)
Mit Volltextzugriff
(516)

Publikationsform

Artikel
(639)

Sprache

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry

Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis

Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials

Native T1 and Extracellular Volume in Transthyretin Amyloidosis

Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component

Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis

Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome

Primary care provider practices and beliefs related to cervical cancer screening with the HPV test in Federally Qualified Health Centers

Efficacy of bortezomib, cyclophosphamide and dexamethasone in treatment-naïve patients with high-risk cardiac AL amyloidosis (Mayo Clinic stage III)

Natural History and Outcome in Systemic AA Amyloidosis

A study of implanted cardiac rhythm recorders in advanced cardiac AL amyloidosis

Bortezomib With or Without Dexamethasone in Primary Systemic (Light Chain) Amyloidosis

Systemic Amyloidosis in England: an epidemiological study

Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis

RAD21 cohesin overexpression is a prognostic and predictive marker exacerbating poor prognosis in KRAS mutant colorectal carcinomas

Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes

A matched comparison of cyclophosphamide, bortezomib and dexamethasone (CVD) versus risk-adapted cyclophosphamide, thalidomide and dexamethasone (CTD) in AL amyloidosis

Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein

Extracellular volume quantification by dynamic equilibrium cardiac computed tomography in cardiac amyloidosis

Different APC genotypes in proximal and distal sporadic colorectal cancers suggest distinct WNT/β-catenin signalling thresholds for tumourigenesis

The effect of changes in cardiac output on middle cerebral artery mean blood velocity at rest and during exercise

Therapeutic blockade of interleukin-6 by tocilizumab in the management of AA amyloidosis and chronic inflammatory disorders: a case series and review of the literature

Misdiagnosis of Hereditary Amyloidosis as AL (Primary) Amyloidosis

Safety and efficacy of risk-adapted cyclophosphamide, thalidomide, and dexamethasone in systemic AL amyloidosis

Aktive Filter

Suchergebnisse filtern